PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2011Annual Review of Public Health303 citations

Proportion of the Decline in Cardiovascular Mortality Disease due to Prevention Versus Treatment: Public Health Versus Clinical Care

View Full Paper
EFEarl S. FordNorthwestern UniversitySCSimon CapewellUniversity of Liverpool

Key Result

Improvements in risk factors and changes in cardiac treatments have both contributed to reductions in coronary heart disease mortality, with models suggesting further reductions are feasible.

PICO

P
Population
Coronary heart disease (CHD)
I
Intervention / Comparator
Prevention (improvements in risk factors) and clinical treatments
O
Primary Outcome
CHD mortality

Abstract

Mortality rates from coronary heart disease (CHD), which had risen during the twentieth century in many countries, started declining in some countries during the 1960s. Once initial skepticism about the validity of the observed trends dissipated, researchers attempted to generate explanations about the events that had transpired using a variety of techniques, including ecological examinations of the trends in risk factors for CHD and changes in management of CHD, multivariate risk equations, and increasingly sophisticated modeling techniques. Improvements in risk factors as well as changes in cardiac treatments have both contributed to the reductions in CHD mortality, although estimates of their contributions have varied among countries. Models suggest that additional large reductions in CHD mortality are feasible by either improving the distribution of risk factors in the population or raising the percentage of patients receiving evidence-based treatments.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ford et al. (2011) conducted a review in Coronary heart disease (CHD). Prevention (improvements in risk factors) and clinical treatments was evaluated on CHD mortality. Improvements in risk factors and changes in cardiac treatments have both contributed to reductions in coronary heart disease mortality, with models suggesting further reductions are feasible.

synapsesocial.com/papers/6a0c6fe7a36b1d7944e895bchttps://doi.org/10.1146/annurev-publhealth-031210-101211
Ask AI
Helpful
Bookmark
Share
View Full Paper